UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

The New England journal of medicine, 2019-12, Vol.381 (25), p.2429-2439

2019

Volltextzugriff (PDF)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

The Journal of infectious diseases, 2023-03, Vol.227 (6), p.761-772

2023

Volltextzugriff (PDF)

Toll-like receptors' two-edged sword: when immunity meets apoptosis

European journal of immunology, 2007-12, Vol.37 (12), p.3311-3318

2007

Volltextzugriff (PDF)

Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?

Clinical cancer research, 2007-08, Vol.13 (15), p.4565-4574

2007

Volltextzugriff (PDF)

TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells

Journal of Immunology, 2006-04, Vol.176 (8), p.4894-4901

2006

Volltextzugriff (PDF)

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4 + T cell immunity within the FLUCOP consortium

Frontiers in immunology, 2022-10, Vol.13, p.982887-982887

2022

Volltextzugriff (PDF)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Frontiers in immunology, 2023-10, Vol.14, p.1260146-1260146

2023

Volltextzugriff (PDF)

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Human vaccines & immunotherapeutics, 2021-11, Vol.17 (11), p.4132-4143

2021

Volltextzugriff (PDF)

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Cancer research (Chicago, Ill.), 2011-03, Vol.71 (5), p.1607-1614

2011

Volltextzugriff (PDF)

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

npj vaccines, 2019-12, Vol.4 (1), p.51-51, Article 51

2019

Volltextzugriff (PDF)

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

Journal of translational medicine, 2011-04, Vol.9 (1), p.44-44, Article 44

2011

Volltextzugriff (PDF)

Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

Journal of hepatology, 2023-06, Vol.78, p.S1167-S1169

2023

Volltextzugriff (PDF)

SAT-196 - Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

Journal of hepatology, 2023-06, Vol.78, p.S1167-S1169

2023

Volltextzugriff (PDF)

CD208/Dendritic Cell-Lysosomal Associated Membrane Protein Is a Marker of Normal and Transformed Type II Pneumocytes

The American journal of pathology, 2004-03, Vol.164 (3), p.861-871

2004

Volltextzugriff (PDF)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1750-1760

2018

Volltextzugriff (PDF)

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

Vaccine, 2020-02, Vol.38 (8), p.1953-1961

2020

Volltextzugriff (PDF)

IκB Kinase β Phosphorylates Dok1 Serines in Response to TNF, IL-1, or γ Radiation

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (50), p.17416-17421

2004

Volltextzugriff (PDF)

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

The Journal of infectious diseases, 2021-12, Vol.224 (12), p.2025-2034

2021

Volltextzugriff (PDF)

Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study

The Journal of infectious diseases, 2024-02, Vol.229 (2), p.355-366

2024

Volltextzugriff (PDF)

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Immunity (Cambridge, Mass.), 2013-04, Vol.38 (4), p.742-753

2013

Volltextzugriff (PDF)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

The Journal of infectious diseases, 2021-10, Vol.224 (7), p.1139-1146

2021

Volltextzugriff (PDF)

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

The Journal of infectious diseases, 2024-07, Vol.230 (1), p.e102-e110

2024

Volltextzugriff (PDF)

Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols

Journal of immunological methods, 2023-12, Vol.523, p.113584-113584, Article 113584

2023

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(93)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

Toll-like receptors' two-edged sword: when immunity meets apoptosis

Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?

TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4 + T cell immunity within the FLUCOP consortium

Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

SAT-196 - Cell-mediated immunity analysis to assess the characteristics of immune response to bepirovirsen: Examples from the B-Clear study

CD208/Dendritic Cell-Lysosomal Associated Membrane Protein Is a Marker of Normal and Transformed Type II Pneumocytes

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

IκB Kinase β Phosphorylates Dok1 Serines in Response to TNF, IL-1, or γ Radiation

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols

Suchergebnisse filtern